Head and neck cancer, treatment, evolution and post therapeutic survival - Part 2: a decade's results 1993-2002.
OBJECTIVE
In the second part of an analysis of a 10-year period of treating oral cancer patients, the focus was the efficiency of treatment, recurrence rates and survival.


METHODS
From 1485 patients with oral and maxillofacial malignant tumours, 1072 cases could be evaluated. The following data were analyzed statistically: patients' charts and medical records including the follow-up reports.


RESULTS
From all patients studied, 811 underwent surgical treatment alone, the mean recurrence rate was 23%. The recurrence rate after surgery plus radiotherapy was 38%; after surgical treatment alone it was 23%; the survival rate at 3 and 5 years post-therapeutically was 49% and 31%, respectively.


CONCLUSIONS
The first choice therapy for carcinomas is surgical. The recurrence rate increased with lymph node involvement and tumour size.
Lung
Teofil
T
Department of Oral and Maxillofacial Surgery, University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania.
Tăşcău
Oana Cristina
OC
Almăşan
Horea Artimoniu
HA
Mureşan
Ovidiu
O
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002280:Basal Cell Carcinoma / Q000401:mortality* / Q000628:therapy; D002294:Carcinoma, Squamous Cell / Q000401:mortality* / Q000628:therapy; D003131:Combined Modality Therapy / Q000379:methods; D005260:Female; D006258:Head and Neck Neoplasms / Q000401:mortality* / Q000628:therapy; D006801:Humans; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000401:mortality; D012383:Romania / Q000453:epidemiology